A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

NCT00660218 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell

Interventions

DRUG: paclitaxel poliglumex
BIOLOGICAL: cetuximab
RADIATION: radiation therapy (IMRT or 3D-CRT)

Sponsor

State University of New York - Upstate Medical University

Collaborators

[object Object]